PAS
IDXX icon

Point72 Asia (Singapore)’s Idexx Laboratories IDXX Stock Holding History

Point72 Asia (Singapore)’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,328
Closed -$671K – 1027
2024
Q3 		$671K Buy
+1,328
New +$645K 0.13% 125

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Point72 Asia (Singapore)'s IDXX Position: Q4 2024 in Review

Point72 Asia (Singapore) sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 1,328 shares — an estimated $671K sold.

Point72 Asia (Singapore) first reported a position in IDXX in Q3 2024 and held it in 1 quarter. The position peaked at $671K in Q3 2024. 1,123 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Point72 Asia (Singapore) reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 1,328 Idexx Laboratories shares in Q4 2024, an estimated $671K.
  • Point72 Asia (Singapore) first reported a position in Idexx Laboratories in Q3 2024 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s Idexx Laboratories position peaked at $671K in Q3 2024.
  • 1,123 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q4 2024, filed 14 Feb 2025.